These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4732710)

  • 1. [Effect of clofibrate on serum lipid pattern in patients with arteriosclerosis].
    Markiewicz K; Walasek L; Pelka W; Lutz W
    Pol Tyg Lek; 1973 Jul; 28(30):1144-7. PubMed ID: 4732710
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic effect of pyridylcarbinolic ester of clofibric acid on the changes of the lipid and fibrinolytic picture in arteriosclerotic patients].
    Rugginenti
    Minerva Med; 1974 May; 65(35):1906-16. PubMed ID: 4601840
    [No Abstract]   [Full Text] [Related]  

  • 3. The influence of Clofibrat on plasma lipid levels.
    Szostak WB; Cybulska B; Ruzyllo E
    Mater Med Pol; 1971; 3(4):12-4. PubMed ID: 5162168
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of long-term administration of clofibrate on the composition of blood lipids in patients with atherosclerosis.
    Poleszak J; Korolko A
    Pol Med J; 1972; 11(2):250-6. PubMed ID: 5071512
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of long-term administration of clofibrate on the composition of blood lipids in atherosclerotic patients].
    Poleszak J; Korolko A
    Pol Tyg Lek; 1971 Jul; 26(29):1106-9. PubMed ID: 5098907
    [No Abstract]   [Full Text] [Related]  

  • 6. Study of serum lipid fractions as related to blood coagulation, fibrinolysis and platelet aggregation in cholesterol fed rabbits and in arteriosclerotic patients given clofibrate.
    Baldoni E; Egge H; Cuttin S; Murawski U; Gibelli A; Giarola P
    Farmaco Sci; 1973 Sep; 28(9):713-21. PubMed ID: 4749857
    [No Abstract]   [Full Text] [Related]  

  • 7. [Changes in the spectrum of serum lipids following 3 months administration of clofibrate Spofa].
    Cagánova A; Cagan S
    Cesk Farm; 1971 Nov; 20(9):341-6. PubMed ID: 5136172
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects of clofibrate on fibrinolysis and platelet adhesiveness and aggregation in patients with arteriosclerosis].
    Cajozzo A; Abbadessa V; Carreca I; Perricone R
    Boll Soc Ital Cardiol; 1973; 18(4):361-7. PubMed ID: 4807075
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of clofibrate, Isopharm, on fat tolerance in atherosclerotic patients].
    Passowicz L
    Pol Tyg Lek; 1972 Jul; 27(30):1163-6. PubMed ID: 5073024
    [No Abstract]   [Full Text] [Related]  

  • 10. [Changes of the humoral lipid picture in arteriosclerotis subjects treated with clofibrate].
    Notarbartolo A; Rini GB; Di Fede G
    Boll Soc Ital Cardiol; 1973; 18(4):384-94. PubMed ID: 4807079
    [No Abstract]   [Full Text] [Related]  

  • 11. [Arteriosclerosis with special reference to anticholesteremic agents].
    Murakami M; Sekimoto H; Nakada I; Takegoshi T; Iwaki N
    Naika; 1970 Jun; 25(6):1082-6. PubMed ID: 5431239
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical trials of plafibride in geriatric patients.
    Demichelis Genesio MA; Bracons R; Vicens B; Zapatero J; Bruseghini L
    Arzneimittelforschung; 1981; 31(10a):1852-5. PubMed ID: 7198465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of clofibrate therapy on serum lipids and lipoproteins].
    Romics L; Szondy E; Gerö S
    Orv Hetil; 1980 Feb; 121(6):321-3. PubMed ID: 7366989
    [No Abstract]   [Full Text] [Related]  

  • 14. [The clinical and biochemical aspects of clofibrate].
    Ylikahri R; Kähönen M
    Duodecim; 1972; 88(10):688-99. PubMed ID: 5068884
    [No Abstract]   [Full Text] [Related]  

  • 15. [Changes of the electrophoretic tracing of the serum glycoproteins in arteriosclerotic patients treated with clofibrate].
    Notarbartolo A; Rini GB; Campisi D
    Boll Soc Ital Cardiol; 1973; 18(4):373-8. PubMed ID: 4807077
    [No Abstract]   [Full Text] [Related]  

  • 16. [Lipid reduction in simultaneous low-substance load. Experience from a community practice].
    Senft D; Wimmer G; Forstbauer R
    Med Welt; 1978 Sep; 29(38):1499-502. PubMed ID: 692346
    [No Abstract]   [Full Text] [Related]  

  • 17. [The importance of pyridinolcarbamate and clofibrate association in the treatment of arteriosclerosis].
    Pola P
    Minerva Cardioangiol; 1975 Apr; 23(4):261-9. PubMed ID: 1095958
    [No Abstract]   [Full Text] [Related]  

  • 18. [The importance of pyridinolcarbamate and clofibrate association in the treatment of arteriosclerosis].
    Pola P
    J Pharm Sci; 1975 Jan; 64(1):261-9. PubMed ID: 1094102
    [No Abstract]   [Full Text] [Related]  

  • 19. [Morphochemical and biochemical principles of atherosclerosis pharmacotherapy].
    Godlewski HG
    Postepy Hig Med Dosw; 1977; 31(2):171-230. PubMed ID: 329244
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapeutic results with combination of pyridinolcarbamate and clofibrate in atherosclerotic patients].
    Valiensi M; Riboli E; Lombardi M
    Minerva Cardioangiol; 1976 Feb; 24(2):148-54. PubMed ID: 1256654
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.